Gorman-Rupp Co
F:GO4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gorman-Rupp Co
F:GO4
|
US |
|
V
|
Viking Therapeutics Inc
F:1VT
|
US |
|
M
|
Mitsubishi Corp
XMUN:MBI
|
JP |
|
DBV Technologies SA
PAR:DBV
|
FR |
|
S
|
Sprint Bioscience AB
XMUN:5JA1
|
SE |
|
Custom Truck One Source Inc
NYSE:CTOS
|
US |
|
N
|
Natural Gas Services Group Inc
XBER:NGS
|
US |
|
B
|
Belden Inc
F:QCTA
|
US |
|
F
|
Ford Motor Co
BMV:F
|
US |
Wall St Price Targets
GO4 Price Targets Summary
Gorman-Rupp Co
According to Wall Street analysts, the average 1-year price target for GO4 is 40.38 EUR with a low forecast of 39.44 EUR and a high forecast of 42.12 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GO4's stock price target?
Price Target
40.38
EUR
According to Wall Street analysts, the average 1-year price target for GO4 is 40.38 EUR with a low forecast of 39.44 EUR and a high forecast of 42.12 EUR.
What is the Revenue forecast for Gorman-Rupp Co?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 2 years is 7%.
What is the Operating Income forecast for Gorman-Rupp Co?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is 8%.
What is the Net Income forecast for Gorman-Rupp Co?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 2 years is 22%.
